<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Compound Licensing NDA | Drug Candidate IP Protection | Terms.Law</title>
  <meta name="description" content="NDA templates for drug compound licensing discussions, compound evaluations, and biotech partnership negotiations. Strong patent protection with invention disclosure obligations and non-circumvention provisions.">
  <link rel="canonical" href="https://terms.law/NDA/industry-packs/biotech/compound-licensing-nda.html">

  <script type="application/ld+json">
  {"@context":"https://schema.org","@type":"FAQPage","mainEntity":[
  {"@type":"Question","name":"How do compound licensing NDAs protect patent rights?","acceptedAnswer":{"@type":"Answer","text":"Compound licensing NDAs protect patents through: invention disclosure obligations, publication delay rights (60-90 days for filing), prohibition on prior art searches using disclosed information, clear IP ownership for improvements, non-circumvention clauses preventing competitive development, and confidentiality periods long enough to cover patent prosecution (5-10 years)."}},
  {"@type":"Question","name":"What is the patent bar date issue in biotech NDAs?","acceptedAnswer":{"@type":"Answer","text":"Patent bar dates are deadlines for filing patent applications. In the US, you have 12 months from public disclosure (grace period). In Europe and most other countries, there is NO grace period - any disclosure before filing destroys novelty. This makes pre-filing confidentiality absolutely critical for biotech innovations."}},
  {"@type":"Question","name":"What compound information needs NDA protection?","acceptedAnswer":{"@type":"Answer","text":"Protected compound information includes: chemical structure, synthesis routes, formulation details, mechanism of action, efficacy and safety data, manufacturing processes, patent prosecution strategy, regulatory submission plans, competitive positioning, and pricing/market projections. Even the existence of a development program may be confidential."}},
  {"@type":"Question","name":"How long should compound licensing NDAs last?","acceptedAnswer":{"@type":"Answer","text":"Compound licensing NDAs typically last 5-10 years, significantly longer than standard 2-3 year business NDAs. This extended period covers: patent prosecution timeline (3-5 years), development period, and maintains protection through product launch. Trade secrets (manufacturing know-how) may have perpetual protection."}}
  ]}
  </script>

  <!-- Google Analytics -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-901N2Y3CDZ"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());
    gtag('config', 'G-901N2Y3CDZ');
  </script>

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
  <style>
    :root {
      --primary: #2563eb;
      --primary-dark: #1d4ed8;
      --accent: #8b5cf6;
      --success: #10b981;
      --warning: #f59e0b;
      --danger: #ef4444;
      --biotech: #7c3aed;
      --biotech-dark: #6d28d9;
      --biotech-light: #f5f3ff;
      --licensing: #059669;
      --licensing-dark: #047857;
      --licensing-light: #ecfdf5;
      --dark: #0f172a;
      --dark-lighter: #1e293b;
      --gray-50: #f8fafc;
      --gray-100: #f1f5f9;
      --gray-200: #e2e8f0;
      --gray-300: #cbd5e1;
      --gray-400: #94a3b8;
      --gray-500: #64748b;
      --gray-600: #475569;
      --gray-700: #334155;
      --gray-800: #1e293b;
    }

    * { box-sizing: border-box; margin: 0; padding: 0; }
    html { scroll-behavior: smooth; }
    body {
      font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
      background: var(--gray-50);
      color: var(--gray-700);
      line-height: 1.6;
    }

    /* Header */
    .site-header {
        background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
        position: sticky;
        top: 0;
        z-index: 1000;
        box-shadow: 0 4px 20px rgba(0,0,0,0.3);
    }
    .header-content {
        max-width: 1400px;
        margin: 0 auto;
        display: flex;
        align-items: center;
        padding: 0 24px;
        height: 60px;
    }
    .site-logo {
        font-size: 1.15rem;
        font-weight: 800;
        text-decoration: none;
        background: linear-gradient(135deg, #60a5fa 0%, #a78bfa 100%);
        -webkit-background-clip: text;
        -webkit-text-fill-color: transparent;
        margin-right: 32px;
    }
    .site-nav {
        display: flex;
        align-items: center;
        gap: 0;
        flex: 1;
    }
    .nav-link {
        padding: 18px 16px;
        color: #94a3b8;
        text-decoration: none;
        font-size: 14px;
        font-weight: 500;
        transition: all 0.2s;
    }
    .nav-link:hover { color: #fff; }
    .nav-cta {
        margin-left: auto;
        background: linear-gradient(135deg, #2563eb 0%, #7c3aed 100%);
        color: #fff !important;
        padding: 10px 20px !important;
        border-radius: 8px;
        font-weight: 600 !important;
    }

    /* Breadcrumb */
    .breadcrumb {
      background: var(--gray-100);
      padding: 12px 24px;
      font-size: 0.85rem;
    }
    .breadcrumb-inner {
      max-width: 1400px;
      margin: 0 auto;
    }
    .breadcrumb a {
      color: var(--gray-500);
      text-decoration: none;
    }
    .breadcrumb a:hover {
      color: var(--biotech);
    }
    .breadcrumb span {
      color: var(--gray-400);
      margin: 0 8px;
    }
    .breadcrumb .current {
      color: var(--gray-700);
      font-weight: 600;
    }

    /* Hub Sub-Navigation */
    .hub-subnav {
      background: linear-gradient(135deg, #6d28d9 0%, #7c3aed 100%);
    }
    .hub-subnav-content {
      max-width: 1400px;
      margin: 0 auto;
      padding: 0 24px;
      display: flex;
      align-items: center;
      justify-content: space-between;
      height: 48px;
    }
    .hub-subnav-title {
      color: #fff;
      font-size: 0.9rem;
      font-weight: 700;
      text-decoration: none;
    }
    .hub-subnav-tabs { display: flex; gap: 8px; }
    .hub-tab {
      padding: 8px 16px;
      color: rgba(255,255,255,0.8);
      text-decoration: none;
      font-size: 0.85rem;
      font-weight: 500;
      border-radius: 6px;
      transition: all 0.2s;
    }
    .hub-tab:hover { background: rgba(255,255,255,0.15); color: #fff; }
    .hub-tab.active { background: rgba(255,255,255,0.2); color: #fff; }

    /* Hero */
    .hero {
      background: linear-gradient(135deg, #047857 0%, #059669 50%, #10b981 100%);
      padding: 3rem 2rem;
    }
    .hero-inner {
      max-width: 900px;
      margin: 0 auto;
      text-align: center;
    }
    .hero-badge {
      display: inline-flex;
      align-items: center;
      gap: 8px;
      background: rgba(255,255,255,0.15);
      border: 1px solid rgba(255,255,255,0.3);
      padding: 6px 16px;
      border-radius: 100px;
      font-size: 0.8rem;
      color: #fff;
      margin-bottom: 1.5rem;
    }
    .hero h1 {
      font-size: 2.5rem;
      font-weight: 800;
      color: white;
      margin-bottom: 1rem;
    }
    .hero-sub {
      font-size: 1.1rem;
      color: rgba(255,255,255,0.9);
      max-width: 650px;
      margin: 0 auto;
    }

    /* Main Content */
    .main-content {
      max-width: 1200px;
      margin: 0 auto;
      padding: 3rem 2rem;
    }

    /* Section Styles */
    .section { margin-bottom: 3rem; }
    .section h2 {
      font-size: 1.75rem;
      font-weight: 800;
      color: var(--dark);
      margin-bottom: 1.5rem;
      display: flex;
      align-items: center;
      gap: 12px;
    }

    /* Patent Protection Section */
    .patent-section {
      background: #fef2f2;
      border: 2px solid #fecaca;
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 3rem;
    }
    .patent-section h2 { color: #991b1b; }
    .patent-grid {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 1.5rem;
      margin-top: 1.5rem;
    }
    @media (max-width: 768px) { .patent-grid { grid-template-columns: 1fr; } }
    .patent-card {
      background: white;
      border-radius: 12px;
      padding: 1.5rem;
    }
    .patent-card.critical {
      border: 2px solid #dc2626;
    }
    .patent-card h4 {
      font-size: 1rem;
      font-weight: 700;
      color: var(--dark);
      margin-bottom: 0.5rem;
      display: flex;
      align-items: center;
      gap: 8px;
    }
    .patent-card p {
      font-size: 0.9rem;
      color: var(--gray-600);
    }

    /* Jurisdiction Comparison */
    .jurisdiction-section {
      background: var(--licensing-light);
      border: 2px solid #a7f3d0;
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 3rem;
    }
    .jurisdiction-section h2 { color: var(--licensing-dark); }
    .jurisdiction-table {
      width: 100%;
      margin-top: 1.5rem;
      border-collapse: collapse;
      background: white;
      border-radius: 12px;
      overflow: hidden;
    }
    .jurisdiction-table th,
    .jurisdiction-table td {
      padding: 1rem;
      text-align: left;
      border-bottom: 1px solid var(--gray-100);
    }
    .jurisdiction-table th {
      background: var(--gray-50);
      font-weight: 700;
      color: var(--dark);
      font-size: 0.9rem;
    }
    .jurisdiction-table td {
      font-size: 0.9rem;
      color: var(--gray-600);
    }
    .grace-yes { color: var(--success); font-weight: 600; }
    .grace-no { color: var(--danger); font-weight: 600; }

    /* Compound Information */
    .compound-section {
      background: white;
      border: 2px solid var(--gray-200);
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 3rem;
    }
    .compound-grid {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 1rem;
      margin-top: 1.5rem;
    }
    @media (max-width: 900px) { .compound-grid { grid-template-columns: 1fr; } }
    .compound-item {
      background: var(--gray-50);
      border-radius: 10px;
      padding: 1.25rem;
    }
    .compound-item h4 {
      font-size: 0.95rem;
      font-weight: 700;
      color: var(--dark);
      margin-bottom: 0.5rem;
      display: flex;
      align-items: center;
      gap: 8px;
    }
    .compound-item ul {
      list-style: none;
      font-size: 0.85rem;
      color: var(--gray-600);
    }
    .compound-item li {
      padding: 0.25rem 0;
    }
    .compound-item li::before {
      content: "\2022";
      color: var(--licensing);
      margin-right: 8px;
    }

    /* Non-Circumvention */
    .circumvention-section {
      background: #fffbeb;
      border: 2px solid #fcd34d;
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 3rem;
    }
    .circumvention-section h2 { color: #92400e; }
    .circumvention-provisions {
      display: grid;
      grid-template-columns: repeat(2, 1fr);
      gap: 1rem;
      margin-top: 1.5rem;
    }
    @media (max-width: 768px) { .circumvention-provisions { grid-template-columns: 1fr; } }
    .circumvention-item {
      background: white;
      border-radius: 10px;
      padding: 1.25rem;
    }
    .circumvention-item h4 {
      font-size: 0.95rem;
      font-weight: 600;
      color: var(--dark);
      margin-bottom: 0.5rem;
      display: flex;
      align-items: center;
      gap: 8px;
    }
    .circumvention-item p {
      font-size: 0.85rem;
      color: var(--gray-600);
    }

    /* Duration Section */
    .duration-section {
      background: var(--biotech-light);
      border: 2px solid #c4b5fd;
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 3rem;
    }
    .duration-section h2 { color: var(--biotech-dark); }
    .duration-comparison {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 1.5rem;
      margin-top: 1.5rem;
    }
    @media (max-width: 768px) { .duration-comparison { grid-template-columns: 1fr; } }
    .duration-card {
      background: white;
      border-radius: 12px;
      padding: 1.5rem;
      text-align: center;
    }
    .duration-card.recommended {
      border: 2px solid var(--biotech);
    }
    .duration-years {
      font-size: 2rem;
      font-weight: 800;
      color: var(--biotech);
      margin-bottom: 0.5rem;
    }
    .duration-card h4 {
      font-size: 1rem;
      font-weight: 700;
      color: var(--dark);
      margin-bottom: 0.25rem;
    }
    .duration-card p {
      font-size: 0.85rem;
      color: var(--gray-600);
    }
    .duration-tag {
      display: inline-block;
      background: var(--biotech-light);
      color: var(--biotech-dark);
      font-size: 0.7rem;
      font-weight: 600;
      padding: 2px 8px;
      border-radius: 4px;
      margin-top: 0.5rem;
    }

    /* Invention Disclosure */
    .invention-section {
      background: white;
      border: 2px solid var(--gray-200);
      border-radius: 16px;
      padding: 2rem;
      margin-bottom: 3rem;
    }
    .invention-flow {
      display: flex;
      align-items: center;
      justify-content: space-between;
      margin: 2rem 0;
      position: relative;
    }
    .invention-flow::before {
      content: '';
      position: absolute;
      top: 30px;
      left: 80px;
      right: 80px;
      height: 4px;
      background: var(--gray-200);
    }
    .flow-step {
      text-align: center;
      position: relative;
      z-index: 1;
    }
    .flow-icon {
      width: 60px;
      height: 60px;
      background: var(--licensing);
      border-radius: 50%;
      display: flex;
      align-items: center;
      justify-content: center;
      color: white;
      font-size: 1.5rem;
      margin: 0 auto 0.5rem;
    }
    .flow-label {
      font-size: 0.8rem;
      color: var(--gray-600);
      max-width: 120px;
    }
    @media (max-width: 768px) {
      .invention-flow { flex-direction: column; gap: 1.5rem; }
      .invention-flow::before { display: none; }
    }

    /* Sample Clause */
    .sample-clause {
      background: var(--gray-50);
      border-left: 4px solid var(--licensing);
      padding: 1rem;
      font-size: 0.85rem;
      font-style: italic;
      color: var(--gray-600);
      border-radius: 0 8px 8px 0;
      margin-top: 1rem;
    }

    /* Generator CTA */
    .generator-cta {
      background: linear-gradient(135deg, var(--licensing) 0%, var(--licensing-dark) 100%);
      border-radius: 16px;
      padding: 2.5rem;
      text-align: center;
      margin-bottom: 3rem;
    }
    .generator-cta h2 {
      font-size: 1.75rem;
      font-weight: 800;
      color: white;
      margin-bottom: 0.5rem;
    }
    .generator-cta p {
      color: rgba(255,255,255,0.9);
      margin-bottom: 1.5rem;
    }
    .generator-cta .btn {
      background: white;
      color: var(--licensing-dark);
      padding: 1rem 2rem;
      border-radius: 10px;
      font-weight: 700;
      font-size: 1rem;
      text-decoration: none;
      display: inline-block;
      transition: all 0.2s;
    }
    .generator-cta .btn:hover {
      transform: translateY(-2px);
      box-shadow: 0 10px 20px rgba(0,0,0,0.2);
    }

    /* Attorney Disclaimer */
    .attorney-disclaimer {
      background: #f0f9ff;
      border: 2px solid #0ea5e9;
      border-radius: 12px;
      padding: 1.5rem;
      text-align: center;
      margin-bottom: 3rem;
    }
    .attorney-disclaimer h4 {
      color: #0369a1;
      font-size: 1rem;
      font-weight: 700;
      margin-bottom: 0.5rem;
    }
    .attorney-disclaimer p {
      color: #0c4a6e;
      font-size: 0.9rem;
    }
    .attorney-disclaimer a {
      color: #0369a1;
      font-weight: 600;
    }

    /* Footer */
    .footer {
      background: var(--dark);
      padding: 3rem 2rem;
      color: var(--gray-300);
    }
    .footer-inner {
      max-width: 1200px;
      margin: 0 auto;
      display: flex;
      justify-content: space-between;
      align-items: center;
    }
    .footer-links { display: flex; gap: 2rem; }
    .footer-links a {
      color: var(--gray-300);
      text-decoration: none;
      font-size: 0.9rem;
    }
    .footer-links a:hover { color: white; }

    @media (max-width: 768px) {
      .hero h1 { font-size: 2rem; }
      .footer-inner { flex-direction: column; gap: 1rem; text-align: center; }
      .hub-subnav-tabs { display: none; }
    }
  </style>
</head>
<body>

<!-- Header -->
<header class="site-header">
    <div class="header-content">
        <a href="/" class="site-logo">Terms.Law</a>
        <nav class="site-nav">
            <a href="/NDA/" class="nav-link">NDA Studio</a>
            <a href="/NDA/industry-packs/" class="nav-link">Industry Packs</a>
            <a href="/NDA/clause-library/" class="nav-link">Clause Library</a>
            <a href="mailto:owner@terms.law" class="nav-link nav-cta">Contact</a>
        </nav>
    </div>
</header>

<!-- Breadcrumb -->
<nav class="breadcrumb">
  <div class="breadcrumb-inner">
    <a href="/">Terms.Law</a>
    <span>&#8250;</span>
    <a href="/NDA/">NDA Studio</a>
    <span>&#8250;</span>
    <a href="/NDA/industry-packs/">Industry Packs</a>
    <span>&#8250;</span>
    <a href="./">Biotech</a>
    <span>&#8250;</span>
    <span class="current">Compound Licensing NDA</span>
  </div>
</nav>

<!-- Hub Sub-Navigation -->
<nav class="hub-subnav">
  <div class="hub-subnav-content">
    <a href="./" class="hub-subnav-title">&#129516; Biotech NDA Pack</a>
    <div class="hub-subnav-tabs">
      <a href="./" class="hub-tab">Overview</a>
      <a href="clinical-trial-nda.html" class="hub-tab">Clinical Trials</a>
      <a href="compound-licensing-nda.html" class="hub-tab active">Licensing</a>
      <a href="research-collaboration-nda.html" class="hub-tab">Research</a>
      <a href="cro-cmo-nda.html" class="hub-tab">CRO/CMO</a>
      <a href="fda-submission-nda.html" class="hub-tab">FDA Filings</a>
    </div>
  </div>
</nav>

<!-- Hero -->
<section class="hero">
  <div class="hero-inner">
    <div class="hero-badge">
      <span>&#128300;</span> IP Protection
    </div>
    <h1>Compound Licensing NDA</h1>
    <p class="hero-sub">
      Maximum IP protection for drug compound licensing discussions, compound evaluations, and partnership negotiations. Built for patent bar date protection and non-circumvention.
    </p>
  </div>
</section>

<!-- Main Content -->
<div class="main-content">

  <!-- Patent Protection Critical -->
  <section class="patent-section" id="patent-protection">
    <h2>&#128680; Patent Bar Date Protection</h2>
    <p>In biotech, premature disclosure can destroy patent rights worldwide. These provisions are essential.</p>

    <div class="patent-grid">
      <div class="patent-card critical">
        <h4>&#9888;&#65039; Pre-Filing Disclosure Risk</h4>
        <p>Any public disclosure before patent filing destroys novelty in most countries. NDAs must ensure all disclosures remain confidential until patents are filed.</p>
      </div>
      <div class="patent-card critical">
        <h4>&#128274; Publication Delay Rights</h4>
        <p>Right to delay any publication or disclosure 60-90 days to file patent applications in all relevant jurisdictions before bar dates expire.</p>
      </div>
      <div class="patent-card">
        <h4>&#128269; Prior Art Search Prohibition</h4>
        <p>Prohibit receiving party from using disclosed information to conduct prior art searches that could be used to challenge patents.</p>
      </div>
      <div class="patent-card">
        <h4>&#128221; Invention Disclosure Obligation</h4>
        <p>Require prompt disclosure of any inventions arising from discussions, with clear ownership assignment to the disclosing party.</p>
      </div>
    </div>

    <div class="sample-clause">
      Receiving Party shall not publish, present, or otherwise disclose any Confidential Information without Disclosing Party's prior written consent. If Receiving Party desires to make any such disclosure, it shall provide Disclosing Party with at least sixty (60) days' prior written notice, during which Disclosing Party may file patent applications. Receiving Party shall not use Confidential Information to conduct prior art searches, patentability analyses, or freedom-to-operate assessments relating to Disclosing Party's technology.
    </div>
  </section>

  <!-- Jurisdiction Grace Periods -->
  <section class="jurisdiction-section">
    <h2>&#127757; Jurisdiction-Specific Patent Grace Periods</h2>
    <p>Patent laws vary dramatically by country. Your NDA strategy must account for the most restrictive jurisdictions.</p>

    <table class="jurisdiction-table">
      <thead>
        <tr>
          <th>Jurisdiction</th>
          <th>Grace Period</th>
          <th>Duration</th>
          <th>NDA Implication</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>United States</td>
          <td class="grace-yes">Yes</td>
          <td>12 months</td>
          <td>Public disclosure starts 12-month clock</td>
        </tr>
        <tr>
          <td>European Union</td>
          <td class="grace-no">No*</td>
          <td>N/A</td>
          <td>Any disclosure before filing = no patent</td>
        </tr>
        <tr>
          <td>Japan</td>
          <td class="grace-yes">Yes</td>
          <td>12 months</td>
          <td>Must file declaration with application</td>
        </tr>
        <tr>
          <td>China</td>
          <td class="grace-no">Limited</td>
          <td>6 months</td>
          <td>Only for specific circumstances</td>
        </tr>
        <tr>
          <td>Canada</td>
          <td class="grace-yes">Yes</td>
          <td>12 months</td>
          <td>Similar to US grace period</td>
        </tr>
      </tbody>
    </table>
    <p style="font-size: 0.8rem; color: var(--gray-500); margin-top: 0.5rem;">*European "grace period" is very limited and only covers abusive disclosures or certain international exhibitions.</p>

    <div class="sample-clause">
      Recognizing that patent rights may be lost in certain jurisdictions if Confidential Information is disclosed prior to patent filing, Receiving Party agrees to maintain strict confidentiality of all compound-related information until Disclosing Party confirms that all necessary patent applications have been filed. This obligation extends to Receiving Party's affiliates, agents, and consultants.
    </div>
  </section>

  <!-- Compound Information Categories -->
  <section class="compound-section">
    <h2>&#128300; Protected Compound Information</h2>
    <p>Drug candidate NDAs must comprehensively define all categories of confidential information.</p>

    <div class="compound-grid">
      <div class="compound-item">
        <h4>&#9879;&#65039; Structural Information</h4>
        <ul>
          <li>Chemical structure/sequence</li>
          <li>Molecular modifications</li>
          <li>Formulation details</li>
          <li>Salt/polymorph forms</li>
          <li>Prodrug designs</li>
        </ul>
      </div>
      <div class="compound-item">
        <h4>&#128202; Efficacy & Safety Data</h4>
        <ul>
          <li>Preclinical study results</li>
          <li>Mechanism of action data</li>
          <li>PK/PD profiles</li>
          <li>Toxicology findings</li>
          <li>Biomarker correlations</li>
        </ul>
      </div>
      <div class="compound-item">
        <h4>&#127981; Manufacturing Know-How</h4>
        <ul>
          <li>Synthesis routes</li>
          <li>Process parameters</li>
          <li>Analytical methods</li>
          <li>Stability data</li>
          <li>Scale-up procedures</li>
        </ul>
      </div>
      <div class="compound-item">
        <h4>&#128196; Patent & IP Strategy</h4>
        <ul>
          <li>Prosecution strategy</li>
          <li>Claim scope plans</li>
          <li>Continuation strategy</li>
          <li>FTO assessments</li>
          <li>Lifecycle planning</li>
        </ul>
      </div>
      <div class="compound-item">
        <h4>&#128176; Commercial Information</h4>
        <ul>
          <li>Pricing projections</li>
          <li>Market positioning</li>
          <li>Competitive analysis</li>
          <li>Partnership terms</li>
          <li>Revenue forecasts</li>
        </ul>
      </div>
      <div class="compound-item">
        <h4>&#128220; Regulatory Strategy</h4>
        <ul>
          <li>Regulatory pathway</li>
          <li>FDA meeting plans</li>
          <li>Filing timelines</li>
          <li>Labeling strategy</li>
          <li>Post-market plans</li>
        </ul>
      </div>
    </div>
  </section>

  <!-- Non-Circumvention -->
  <section class="circumvention-section">
    <h2>&#128683; Non-Circumvention Provisions</h2>
    <p>Prevent receiving parties from using disclosed information to compete or work around your IP.</p>

    <div class="circumvention-provisions">
      <div class="circumvention-item">
        <h4>&#128683; Target Non-Competition</h4>
        <p>Prohibit development of compounds against the same therapeutic target using disclosed information.</p>
      </div>
      <div class="circumvention-item">
        <h4>&#128274; Design-Around Prohibition</h4>
        <p>Prohibit using disclosed information to design around patents or develop functionally equivalent compounds.</p>
      </div>
      <div class="circumvention-item">
        <h4>&#128101; Personnel Restrictions</h4>
        <p>Limit which employees can access information and restrict their work on competitive programs.</p>
      </div>
      <div class="circumvention-item">
        <h4>&#128200; Firewall Requirements</h4>
        <p>Require information barriers between evaluation team and competitive development programs.</p>
      </div>
    </div>

    <div class="sample-clause">
      During the term of this Agreement and for three (3) years thereafter, Receiving Party shall not, directly or indirectly: (a) develop, manufacture, or commercialize any compound that binds to the same molecular target as the Disclosed Compound; (b) use Confidential Information to design around Disclosing Party's patents or develop functionally equivalent compounds; or (c) contact or engage suppliers, collaborators, or investigators identified through Confidential Information without Disclosing Party's written consent.
    </div>
  </section>

  <!-- Duration -->
  <section class="duration-section" id="duration">
    <h2>&#128337; Confidentiality Duration</h2>
    <p>Biotech NDAs require significantly longer protection periods than standard business NDAs.</p>

    <div class="duration-comparison">
      <div class="duration-card">
        <div class="duration-years">2-3</div>
        <h4>Standard Business</h4>
        <p>Typical for general business NDAs</p>
      </div>
      <div class="duration-card recommended">
        <div class="duration-years">5-10</div>
        <h4>Biotech Compound</h4>
        <p>Covers development cycle and patent prosecution</p>
        <span class="duration-tag">Recommended</span>
      </div>
      <div class="duration-card">
        <div class="duration-years">&#8734;</div>
        <h4>Trade Secrets</h4>
        <p>Manufacturing know-how often perpetual</p>
      </div>
    </div>

    <div class="sample-clause">
      The confidentiality obligations hereunder shall continue for a period of ten (10) years from the date of disclosure; provided, however, that with respect to any Confidential Information that constitutes a trade secret under applicable law (including manufacturing processes, analytical methods, and formulation know-how), the confidentiality obligations shall continue for so long as such information remains a trade secret.
    </div>
  </section>

  <!-- Invention Disclosure Flow -->
  <section class="invention-section">
    <h2>&#128161; Invention Disclosure & Ownership</h2>
    <p>Clear processes for handling inventions arising from licensing discussions.</p>

    <div class="invention-flow">
      <div class="flow-step">
        <div class="flow-icon">&#128161;</div>
        <div class="flow-label">Invention conceived during discussions</div>
      </div>
      <div class="flow-step">
        <div class="flow-icon">&#128221;</div>
        <div class="flow-label">Prompt written disclosure to disclosing party</div>
      </div>
      <div class="flow-step">
        <div class="flow-icon">&#128269;</div>
        <div class="flow-label">Joint review of inventorship and ownership</div>
      </div>
      <div class="flow-step">
        <div class="flow-icon">&#128196;</div>
        <div class="flow-label">Assignment or license as agreed</div>
      </div>
    </div>

    <div class="sample-clause">
      Receiving Party shall promptly disclose to Disclosing Party any invention, discovery, or improvement conceived or reduced to practice by Receiving Party's personnel in connection with the evaluation of Confidential Information. Any such invention that is derived from or utilizes Confidential Information shall be owned by Disclosing Party, and Receiving Party shall assign all right, title, and interest therein to Disclosing Party. Joint inventions not derived from Confidential Information shall be jointly owned, with each party having the right to license its interest without accounting to the other.
    </div>
  </section>

  <!-- Generator CTA -->
  <section class="generator-cta">
    <h2>Generate Your Compound Licensing NDA</h2>
    <p>Customize provisions for your specific compound evaluation, licensing discussion, or partnership negotiation.</p>
    <a href="/NDA/generator.html?scenario=compound-licensing" class="btn">Generate Licensing NDA &#8594;</a>
  </section>

  <!-- Attorney Disclaimer -->
  <div class="attorney-disclaimer">
    <h4>&#9878;&#65039; Consult a Patent Attorney</h4>
    <p>Compound licensing involves complex patent strategy, IP valuation, and commercial considerations. We strongly recommend engaging patent counsel experienced in life sciences transactions to review any NDA involving drug candidates. <a href="mailto:owner@terms.law">Request a consultation</a>.</p>
  </div>

</div>

<!-- Footer -->
<footer class="footer">
  <div class="footer-inner">
    <div>&copy; 2025 Terms.Law &mdash; Sergei Tokmakov, Esq. &bull; CA Bar #279869</div>
    <div class="footer-links">
      <a href="/NDA/">NDA Studio</a>
      <a href="./">Biotech Pack</a>
      <a href="mailto:owner@terms.law">Contact</a>
    </div>
  </div>
</footer>

<!-- Chat Widget -->
<script src="/chat-widget/chat-widget.js"></script>

</body>
</html>
